Remove tag hhs
article thumbnail

Clover biopharmaceuticals raises $230 M; BrainStorm after ALS; BARDA grants $5.65 M LightDeck for SARS-CoV-2 antigen test; Libtayo for first-line advanced NSCLC subset

Delveinsight

The company plans to use the capital to expand its pipeline of protein-based vaccines and biologic cancer therapies utilizing its innovative and proprietary Trimer-Tag technology platform. The company develops transformative biologics including vaccines and therapeutics for the world’s most debilitating diseases.

article thumbnail

Drug Pricing Reform: Never Out of the Headlines

Intouch Solutions

Department of Health and Human Services (HHS) has been given 45 days (from July 9) to submit a plan that addresses the issues noted above. The majority of new products coming to market are specialty drugs targeting rare diseases and new breakthrough approaches to cancer treatment – but innovation comes with large price tags.

Drugs 52
article thumbnail

Shkreli is sued for monopolizing Daraprim. But what ever happened to Azar’s single source drug import plan?

Pharmacy Checkers

Tagged the “pharma bro” for the cavalier attitude he fronted about his greed, Martin is actually currently behind bars. Martin Shkreli, who became famous overnight back in 2015 for raising the price of Daraprim 5000%, is back in the headlines.

Drugs 54